JDRF Heads—In Person!—to ADA’s 82nd Scientific Sessions

in , , ,

ADA Scientific Sessions June 3-7, 2022

The American Diabetes Association’s (ADA) 82nd Scientific Sessions is almost here! From June 3-7, scientists and healthcare professionals will gather—in person!—at one of the largest conferences of diabetes researchers in the world. JDRF researchers and JDRF-funded scientists will also be there virtually to hear first-hand and present new study results that will improve outcomes for people with diabetes (T1D). Read what’s happening below.

ADA’s 82nd Scientific Sessions

  • The Scientific Sessions is one of the largest gatherings of diabetes researchers in the world, where scientists and healthcare professionals share and learn about new diabetes advances with top experts.
  • JDRF-supported research has been highlighted at this annual event since JDRF started funding research, showcasing new breakthroughs and therapies for people with T1D.
  • This year, researchers will present 120+ studies—with JDRF-funding at present or in the past—encompassing breakthrough clinical trials and significant research studies that are paving the way to novel and emerging treatments for T1D.
  • JDRF-funded researchers will outline new advances like:
Curing T1D
  • Cell Therapies
    • What are the latest advances in stem cell-derived replacement approaches?
  • Disease-Modifying Therapies
    • What role does innate immunity have in type 1?
    • Generating new beta cells in the body: True or false?
  • T1D Screening
    • General vs. targeted screening: Which one is best?
Improving Lives
  • Glucose Control
    • What are the benefits of artificial pancreas systems in real time?
    • How close are we to “smart” insulin?
  • Complications
    • Diabetic kidney disease breakthroughs: Are we ready?
    • A new JDRF staging system for diabetic eye disease: Are we ready for prime time?
  • Psychosocial
    • How do we prevent disparities in T1D intervention and treatment?

Throughout the Scientific Sessions, JDRF will be sharing updates to keep people apprised of the day-to-day happenings:

  • Blog posts before, during, and after the ADA meeting
  • A Facebook Live event (@myJDRF) for each day, taking place the following day from 12:00 p.m. CT, with JDRF-funded scientists talking about the takeaways
  • A “happy hour” with CEO Aaron J. Kowalski, Ph.D., from 7-8 p.m. ET on Tuesday, June 7, speaking about the takeaways from the ADA Scientific Sessions and a Q&A period to answer questions from you, via Facebook Live (@myJDRF)
  • Interviews with JDRF-funded scientists, who will go over their research and what it means to the T1D community, to be pushed out on social media
  • To stay updated, follow us on Facebook (@myJDRF) and Twitter (@JDRF and @JDRFResearch), with the hashtags #JDRFxADA and #ADA2022